Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(9 sites)
United States
City of Hope, Duarte, California Valkyrie Clinical Trials, Los Angeles, California Colorado Blood Cancer Institute, Denver, Colorado New York Medical College, Valhalla, New York University of North Carolina at Chapel Hill/ University of North Carolina Medical Center, Chapel Hill, North Carolina The Ohio State University Wexner Medical Center, Columbus, Ohio Oregon Health & Science University, Portland, Oregon TriStar BMT, Nashville, Tennessee University of Texas MD Anderson Cancer Center, Houston, Texas